5:09 PM
Jan 23, 2012
 |  BC Extra  |  Company News

Guided Therapeutics receives not approvable letter for LuViva

FDA issued a not approvable letter for a PMA from Guided Therapeutics Inc. (OTCBB:GTHP) for LuViva Advanced Cervical Scan to detect cancerous and precancerous cervical tissue. The company said it will seek an independent panel review of the application.


Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >